Molecular confirmation of primary monophasic synovial sarcoma of the mandible: diagnosis and management

Published:February 22, 2022DOI:


      Synovial sarcoma (SS) is a rare, high-grade, soft tissue malignancy that originates from pluripotent mesenchymal stem cells. Knox introduced the term ‘synovial sarcoma’, noting its histological similarity to synovial tissue. SS is seen most frequently in young and middle-aged adults with an equal sex distribution. Symptoms are non-specific and relate to the local effect of the mass. Currently, we know of no specific guidelines for the management of SS in the head and neck. We report a case of primary monophasic SS of the mandible in a 59-year-old male, and outline our diagnostic approach and management.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mallen-St Clair J.
        • Arshi A.
        • Abemayor E.
        • et al.
        Factors associated with survival in patients with synovial cell sarcoma of the head and neck: an analysis of 167 cases using the SEER (Surveillance, Epidemiology, and End Results) database.
        JAMA Otolaryngol Head Neck Surg. 2016; 142: 576-583
        • Hornick J.L.
        Practical soft tissue pathology: a diagnostic approach.
        2nd ed. Elsevier, 2018
        • Sun B.
        • Sun Y.
        • Wang J.
        • et al.
        The diagnostic value of SYT-SSX detected by reverse transcriptase-polymerase chain reaction (RT-PCR) and fluorescence in situ hybridization (FISH) for synovial sarcoma: a review and prospective study of 255 cases.
        Cancer Sci. 2008; 99: 1355-1361
        • Liu Z.
        • Jin S.
        • Fu S.
        • et al.
        Management of the primary intraosseous synovial sarcoma of the jaws: be careful of the surgical margin.
        J Oral Maxillofac Surg. 2015; 73: 550-563
        • Wu Y.
        • Bi W.
        • Han G.
        • et al.
        Influence of neoadjuvant chemotherapy on prognosis of patients with synovial sarcoma.
        World J Surg Oncol. 2017; 15: 101
        • Desar I.M.
        • Fleuren E.D.
        • van der Graaf W.T.
        Systemic treatment for adults with synovial sarcoma.
        Curr Treat Options Oncol. 2018; 19: 13
        • Kalavrezos N.
        • Sinha D.
        Head and neck sarcomas in adulthood: current trends and evolving management concepts.
        Br J Oral Maxillofac Surg. 2020; 58: 890-897
        • Pu J.J.
        • Choi W.S.
        • Yu P.
        • et al.
        Do predetermined surgical margins compromise oncological safety in computer-assisted head and neck reconstruction?.
        Oral Oncol. 2020; 111: 104914
        • Hua J.
        • Aziz S.
        • Shum J.W.
        Virtual surgical planning in oral and maxillofacial surgery.
        Oral Maxillofac Surg Clin North Am. 2019; 31: 519-530
        • Song S.
        • Park J.
        • Kim H.J.
        • et al.
        Effects of adjuvant radiotherapy in patients with synovial sarcoma.
        Am J Clin Oncol. 2017; 40: 306-311